Revisiting Temozolomide's role in solid tumors: Old is gold?

Autor: Matthaios, Dimitrios¹, Balgkouranidou, Ioanna², Neanidis, Konstantinos³, Sofis, Andreas⁴, Pikouli, Anastasia⁵, Romanidis, Konstantinos⁶, Pappa, Aglaia⁷, Karamouzis, Michael⁸, Zygogianni, Anna⁹, Charalampidis, Charalampos¹⁰, Zarogoulidis, Paul¹¹ pzarog@hotmail.com, Rigas, George¹², Galanis, Alex⁷

Publikováno v: Journal of Cancer. 2024, Vol. 15 Issue 11, p3254-3271. 18p.

Current status and progress of concurrent chemoradiotherapy in patients with locally advanced non‐small cell lung cancer prior to the approval of durvalumab.

Autor: Fukui, Tomoya¹ (AUTHOR) tofukui@med.kitasato-u.ac.jp, Hosotani, Shinji¹ (AUTHOR), Soda, Itaru² (AUTHOR), Ozawa, Takahiro¹ (AUTHOR), Kusuhara, Seiichiro¹ (AUTHOR), Kakegawa, Mikiko I.¹ (AUTHOR), Kasajima, Masashi¹ (AUTHOR), Hiyoshi, Yasuhiro¹ (AUTHOR), Igawa, Satoshi¹ (AUTHOR), Yokoba, Masanori³ (AUTHOR), Mitsufuji, Hisashi⁴ (AUTHOR), Kubota, Masaru³ (AUTHOR), Katagiri, Masato³ (AUTHOR), Sasaki, Jiichiro⁵ (AUTHOR), Ishiyama, Hiromichi² (AUTHOR), Naoki, Katsuhiko¹ (AUTHOR)

Publikováno v: Thoracic Cancer. Apr2020, Vol. 11 Issue 4, p1005-1014. 10p.

BCNU (NSC-409962) in the treatment of bronchogenic carcinoma.

Autor: Whittington RM, Fairly JL, Majima H, Patno ME, Prentice R

Publikováno v: Cancer chemotherapy reports [Cancer Chemother Rep] 1972 Dec; Vol. 56 (6), pp. 739-43.

Public health nursing service provided in households.

Autor: FERGUSON M, PATNO ME

Publikováno v: Public health reports (Washington, D.C. : 1896) [Public Health Rep (1896)] 1958 Jul; Vol. 73 (7), pp. 627-33.

Cyclophosphamide vs melphalan in treatment of plasma cell myeloma.

Autor: Rivers SL, Patno ME

Publikováno v: JAMA [JAMA] 1969 Feb 17; Vol. 207 (7), pp. 1328-34.